Browsing Category
Pharma Industry News
4739 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Immuron secures FDA greenlight to begin human studies of IMM-529 against C. difficile infection
Immuron gains FDA IND approval for IMM-529, advancing its oral antibody therapy into human trials for C. difficile infection.
Breakthrough allogeneic immunotherapy from Lunai Bioworks eliminates pancreatic tumors in preclinical study
Find out how Lunai Bioworks’ engineered dendritic-cell therapy achieved complete regression of pancreatic cancer in preclinical models and what it means for solid-tumor immunotherapy.
Inside Azenta’s partnership with the PRECEDE Foundation driving breakthroughs in early pancreatic cancer diagnostics
Discover how Azenta Life Sciences and the PRECEDE Foundation are building a global biobanking network to transform early pancreatic cancer detection.
How Bio-Techne and Nucleai’s AI spatial biology breakthrough could redefine melanoma biomarker discovery
Discover how Bio-Techne and Nucleai’s AI-powered spatial biology workflow is advancing predictive biomarker discovery in melanoma and transforming immunotherapy research.
Compass Pathways fast-tracks COMP360 launch timeline as Q3 2025 results show improved financial runway
Learn how Compass Pathways’ faster COMP360 launch timeline after Q3 2025 results could reshape the psychedelics industry and investor sentiment.
Pfizer Q3 2025 earnings beat forecasts as non-COVID drug sales lift margins and EPS guidance
Find out how Pfizer beat Q3 2025 earnings forecasts and raised full-year EPS guidance as non-COVID drugs and cost savings drove profit growth.
Evoke Pharma stock surges 130% as QOL Medical signs definitive $11-per-share acquisition agreement
Find out how Evoke Pharma’s $11-per-share acquisition by QOL Medical is reshaping specialty pharma and why investors are applauding this record premium.
Relmada gains FDA support for dual Phase 3 study paths of NDV-01 in non-muscle invasive bladder cancer
Find out how Relmada secured FDA alignment on dual Phase 3 paths for NDV-01 in NMIBC, opening two routes toward approval and a potential new bladder-sparing therapy.
Scilex Holding Company signs $10m licensing deal with Datavault AI to commercialize tokenized genomic and drug data assets
Find out how Scilex’s $10 million licensing deal with Datavault AI could revolutionize biotech funding through genomic data tokenization.
Abivax delivers breakthrough Phase 3 data: obefazimod improves quality of life in moderate-to-severe ulcerative colitis
Discover how Abivax’s obefazimod improved quality of life and achieved remission in Phase 3 ulcerative colitis trials—see why experts call it a game changer.